Better Understand Children and Adolescents' Intrafamilial Oppositional Defiant Disorder

NCT03447535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2018-02-27

No results posted yet for this study

Summary

Oppositional Defiant Disorder (ODD) is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5) as: "A pattern of angry/irritable mood, argumentative/defiant behavior, or vindictiveness lasting at least 6 months exhibited during interaction with at least one individual who is not a sibling." "The disturbance in behavior is associated with distress in the individual or others in his or her immediate social context (e.g., family, peer group, work colleagues), or it impacts negatively on social, educational, occupational, or other important areas of functioning." Children with "classic" oppositional defiant disorder, except for mild forms, show symptoms in several settings (at home, at school, with peers).

In this study, the investigators will consider the specifics of children presenting "intrafamilial" oppositional defiant disorder (IODD). These children's symptoms are confined to only one setting: the home. Therefore, the aim of this study will be to characterize children with intrafamilial oppositional defiant disorder. The investigators want to understand the differences between IODD and classical forms of ODD in terms of psychiatric comorbidities, medical histories and cognitive abilities. They also investigate what clinicians currently do to help these families.

Conditions

  • Oppositional Defiant Disorder With Familial Setting

Interventions

OTHER

Semi-directive interview (Kiddy Sads)

semi-directive interview (Kiddy Sads) conducted as part of the care

OTHER

SDQ questionnaires (strenghs and difficulties questionnaire)

SDQ questionnaires (strenghs and difficulties questionnaire) conducted as part of the care

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Elisa BOUSQUET · University Hospital, Montpellier

Eligibility

Min Age
5 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03447535 on ClinicalTrials.gov